Lifemd Preferred Series Preferred Stock Performance
| LFMDP Preferred Stock | USD 22.59 0.11 0.48% |
LifeMD Preferred has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.32, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LifeMD Preferred's returns are expected to increase less than the market. However, during the bear market, the loss of holding LifeMD Preferred is expected to be smaller as well. LifeMD Preferred Series right now secures a risk of 1.45%. Please verify LifeMD Preferred Series potential upside, and the relationship between the total risk alpha and kurtosis , to decide if LifeMD Preferred Series will be following its current price movements.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in LifeMD Preferred Series are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental indicators, LifeMD Preferred is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Actual Historical Performance (%)
One Day Return (0.48) | Five Day Return 3.53 | Year To Date Return 16.74 | Ten Year Return (6.65) | All Time Return (6.65) |
| Begin Period Cash Flow | 9.2 M | |
| Total Cashflows From Investing Activities | -3.4 M |
LifeMD |
LifeMD Preferred Relative Risk vs. Return Landscape
If you would invest 2,167 in LifeMD Preferred Series on September 2, 2024 and sell it today you would earn a total of 92.00 from holding LifeMD Preferred Series or generate 4.25% return on investment over 90 days. LifeMD Preferred Series is currently producing 0.0753% returns and takes up 1.4459% volatility of returns over 90 trading days. Put another way, 12% of traded preferred stocks are less volatile than LifeMD, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
LifeMD Preferred Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LifeMD Preferred's investment risk. Standard deviation is the most common way to measure market volatility of preferred stocks, such as LifeMD Preferred Series, and traders can use it to determine the average amount a LifeMD Preferred's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0521
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | LFMDP | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.45 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average LifeMD Preferred is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LifeMD Preferred by adding it to a well-diversified portfolio.
LifeMD Preferred Fundamentals Growth
LifeMD Preferred Stock prices reflect investors' perceptions of the future prospects and financial health of LifeMD Preferred, and LifeMD Preferred fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LifeMD Preferred Stock performance.
| Return On Equity | -44.07 | ||||
| Return On Asset | -1.17 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | 638.22 M | ||||
| Revenue | 92.88 M | ||||
| EBITDA | (63.04 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 1.41 M | ||||
| Debt To Equity | 0.46 % | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (33.09 M) | ||||
| Earnings Per Share | (2.26) X | ||||
| Total Asset | 49.92 M | ||||
About LifeMD Preferred Performance
Assessing LifeMD Preferred's fundamental ratios provides investors with valuable insights into LifeMD Preferred's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the LifeMD Preferred is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. Lifemd Inc operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.Things to note about LifeMD Preferred Series performance evaluation
Checking the ongoing alerts about LifeMD Preferred for important developments is a great way to find new opportunities for your next move. Preferred Stock alerts and notifications screener for LifeMD Preferred Series help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LifeMD Preferred has high likelihood to experience some financial distress in the next 2 years | |
| LifeMD Preferred Series has accumulated 1.41 M in total debt with debt to equity ratio (D/E) of 0.46, which is about average as compared to similar companies. LifeMD Preferred Series has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist LifeMD Preferred until it has trouble settling it off, either with new capital or with free cash flow. So, LifeMD Preferred's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LifeMD Preferred Series sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LifeMD to invest in growth at high rates of return. When we think about LifeMD Preferred's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 92.88 M. Net Loss for the year was (60.9 M) with profit before overhead, payroll, taxes, and interest of 74.88 M. | |
| LifeMD Preferred Series has accumulated about 5.84 M in cash with (33.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. |
- Analyzing LifeMD Preferred's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LifeMD Preferred's stock is overvalued or undervalued compared to its peers.
- Examining LifeMD Preferred's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LifeMD Preferred's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LifeMD Preferred's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LifeMD Preferred's preferred stock. These opinions can provide insight into LifeMD Preferred's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LifeMD Preferred Stock Analysis
When running LifeMD Preferred's price analysis, check to measure LifeMD Preferred's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD Preferred is operating at the current time. Most of LifeMD Preferred's value examination focuses on studying past and present price action to predict the probability of LifeMD Preferred's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD Preferred's price. Additionally, you may evaluate how the addition of LifeMD Preferred to your portfolios can decrease your overall portfolio volatility.